Sonnet BioTherapeutics I... (SONN)
NASDAQ: SONN
· Real-Time Price · USD
3.53
-0.23 (-6.12%)
At close: Aug 15, 2025, 3:59 PM
3.50
-0.85%
After-hours: Aug 15, 2025, 07:58 PM EDT
Sonnet BioTherapeutics Income Statement
Financials in USD. Fiscal
year is
October - September.
Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | n/a | n/a | 1M | n/a | n/a | n/a | 18.63K | 37.26K | 36.85K | 36.45K | 37.26K | 62.75K | 62.07K | 95.32K | 129.8K | 483.63K | n/a | n/a | n/a |
Cost of Revenue | n/a | 22.09K | 22.19K | 21.61K | 21.04K | 20.5K | 19.97K | 19.47K | 18.98K | 18.87K | 18.43K | 17.93K | 5.65M | 6.41M | 25.45K | 5.04M | 24.07K | 23.51K | 3.87M |
Gross Profit | n/a | -22.09K | 1M | -21.61K | -21.04K | -20.5K | -1.35K | 17.79K | 17.87K | 17.57K | 18.82K | 44.83K | -5.59M | -6.31M | 104.35K | -4.55M | -24.07K | -23.51K | -3.87M |
Operating Income | -3.81M | -4.23M | -2.85M | -3.17M | -3.53M | -3.87M | -1.28M | -3.6M | -3.92M | -5.66M | -5.61M | -7.38M | -7.87M | -8.21M | -6.21M | -6.95M | -6.24M | -6.04M | -5.86M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -3.78M | -3.49M | -3M | -3.13M | -3.51M | 365.43K | -1.17M | -3.68M | -3.95M | -5.67M | -5.54M | -7.44M | -7.88M | -8.21M | -6.2M | -6.95M | -6.12M | -6.04M | -5.88M |
Net Income | -3.78M | -3.49M | -3.16M | -3.13M | -3.51M | 365.43K | -1.17M | -3.68M | -3.95M | -5.67M | -5.54M | -7.49M | -7.89M | -8.21M | -6.17M | -6.95M | -6.12M | -6.04M | -5.88M |
Selling & General & Admin | 1.38M | 2.34M | 1.96M | 1.97M | 1.8M | 1.7M | 653.46K | 1.79M | 1.54M | 1.88M | 1.9M | 2.32M | 2.28M | 1.9M | 2.08M | 2.39M | 2.35M | 2.2M | 2M |
Research & Development | 2.43M | 1.88M | 1.89M | 1.2M | 1.73M | 2.17M | 644.04K | 1.84M | 2.41M | 3.82M | 3.75M | 5.12M | 5.65M | 6.41M | 4.27M | 5.04M | 3.89M | 3.84M | 3.87M |
Other Expenses | n/a | n/a | n/a | -21.61K | n/a | 727.00 | -497 | -19.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.81M | 4.23M | 3.85M | 3.15M | 3.53M | 3.87M | 1.3M | 3.62M | 3.95M | 5.7M | 5.65M | 7.44M | 7.93M | 8.31M | 6.34M | 7.43M | 6.24M | 6.04M | 5.86M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 58.38K | 9.79K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 4.23M | 3.85M | 3.17M | 3.53M | 3.87M | 1.3M | 3.64M | 3.95M | 5.7M | 5.65M | 7.44M | 7.93M | 8.31M | 6.34M | 7.43M | 6.24M | 6.04M | 5.86M |
Income Tax Expense | n/a | n/a | 158.4K | n/a | n/a | n/a | n/a | n/a | 31.43K | 4.61K | n/a | 58.38K | 9.79K | -1.72K | -27.94K | 5.19K | 1.51K | 2.08K | 13.25K |
Shares Outstanding (Basic) | 3.97M | 3.92M | 2.02M | 650.28K | 629.69K | 577.21K | 474.72K | 218.8K | 166.91K | 93.83K | 39.32K | 25.45K | 24.61K | 24.47K | 24.47K | 9.55K | 9.13K | 7.61K | 6.99K |
Shares Outstanding (Diluted) | 3.97M | 3.92M | 2.02M | 650.28K | 629.69K | 577.21K | 474.72K | 218.8K | 166.91K | 93.83K | 39.32K | 25.45K | 24.61K | 24.47K | 24.47K | 9.55K | 9.13K | 7.61K | 6.99K |
EPS (Basic) | -0.95 | -0.89 | -1.56 | -4.81 | -5.57 | 0.63 | -2.46 | -16.8 | -23.65 | -60.4 | -140.94 | -292.17 | -320.15 | -335.45 | -253.42 | -728.19 | -669.67 | -793.93 | -841.04 |
EPS (Diluted) | -0.95 | -0.89 | -1.56 | -4.81 | -5.57 | 0.63 | -2.46 | -16.8 | -23.65 | -60.4 | -140.94 | -292.17 | -320.15 | -335.45 | -253.42 | -728.19 | -669.67 | -793.93 | -841.04 |
EBITDA | -3.81M | -4.21M | -2.83M | -3.15M | -3.51M | -3.85M | -1.26M | -3.58M | -3.9M | -5.65M | -5.59M | -7.36M | -7.84M | -8.18M | -6.19M | -6.92M | -6.22M | -6.01M | -5.84M |
EBIT | n/a | -4.23M | -2.85M | -3.17M | -3.53M | -3.87M | -1.28M | -3.6M | -3.92M | -5.66M | -5.61M | -7.38M | -7.87M | -8.21M | -6.21M | -6.95M | -6.24M | -6.04M | -5.86M |
Depreciation & Amortization | n/a | 22.09K | 22.19K | 21.61K | 21.04K | 20.5K | 19.97K | 19.47K | 18.98K | 18.87K | 18.43K | 17.93K | 23.69K | 26.19K | 25.45K | 24.79K | 24.07K | 23.51K | 22.8K |